Latest profit margin for MindMaze Therapeutics Holding S.A.: -753.6% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
MindMaze Therapeutics Holding S.A. (RLFTY) currently reports a profit margin of -753.6% as of June 2026. That compares with -874.49% in the prior-year period — up 13.8% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore MindMaze Therapeutics Holding S.A.'s profit margin history and peer comparisons.
MindMaze Therapeutics Holding S.A.'s profit margin increased from -874.49% to -753.6% — a 13.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
MindMaze Therapeutics Holding S.A.'s profit margin of -753.6% is lower than the Healthcare sector average of 17.63%. That is roughly 4374.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but MindMaze Therapeutics Holding S.A.'s current -753.6% should be judged against Healthcare norms (sector average: 17.63%) and against RLFTY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -753.6%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for MindMaze Therapeutics Holding S.A., and consider following RLFTY for alerts when major investors trade the stock.